Quantcast

Latest lung cancer Stories

2014-06-25 08:30:28

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Lung Cancer and Melanomahttp://www.reportbuyer.com/pharma_healthcare/diseases/triple_analysis_leukemia_lung_cancer_melanoma.html This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment...

2014-06-24 20:20:47

VANCOUVER, June 24, 2014 /CNW/ - We are pleased to announce that an event to celebrate the launch of Radon Guard was held at the National Research Council of Canada (NRCC) in Ottawa on June 17th, 2014. The event was attended by senior NRCC and Canadian Construction Materials Centre (CCMC) staff, together with members of parliament and industry representatives. Radon Guard is a new, patent pending, structural under-slab ventilation panel system that allows for soil gas removal,...

2014-06-24 14:00:24

NYU Langone Medical Center / New York University School of Medicine Leading experts from renowned academic centers join in one voice to encourage new perspectives in addressing brain cancer A blue-ribbon team of national experts on brain cancer says that professional pessimism and out-of-date "myths," rather than current science, are guiding -- and compromising -- the care of patients with cancers that spread to the brain. In a special article published in the July issue of...

2014-06-24 08:30:32

CAMBRIDGE, Mass., June 24, 2014 /PRNewswire/ -- Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber's Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen's lung cancer discovery pipeline. "We are...

2014-06-23 12:29:48

PARIS, June 23, 2014 /PRNewswire/ -- OSE Pharma SA receives a positive agreement to initiate a Phase 3 clinical trial with OSE-2101, a therapeutic cancer vaccine for non-small cell lung cancer (NSCLC) OSE Pharma SA, a European cancer immunotherapy company with a specific T cytotoxic technology, today announced that it has received positive feedback from an end of Phase 2 / Pre-Phase 3 meeting with the U.S. Food and Drug Administration (FDA) and Scientific Advice from...

2014-06-23 08:26:23

FDA Urged to Stop Harmful Changes Made by Tobacco Industry WASHINGTON, June 23, 2014 /PRNewswire-USNewswire/ -- Design changes and chemical additives introduced by tobacco companies in recent decades have made cigarettes more addictive, more attractive to kids and even more deadly, according to a report issued today by the Campaign for Tobacco-Free Kids. http://photos.prnewswire.com/prnvar/20080918/CFTFKLOGO The report, titled Designed for Addiction, details how tobacco companies purposely...

2014-06-20 23:03:07

Lung Detoxification is a new method created by Mark Freeman that claims to help people detox their body without using pills or drugs. The full review on the site hynguyenblog.com shows whether this method is worth using or not. New York, NY (PRWEB) June 20, 2014 Lung Detoxification is a new method that provides people with a safe method to quit smoking cigarettes effectively. The e-book reveals to people the fastest and easiest way to clean their lungs of the poisonous tar and dangerous...

2014-06-20 23:01:49

Vapor Protection Services announces a radon testing service coupon for Indianapolis area homeowners in support of the Indiana State Board of Health’s new enforcement policy of EPA standards for radon installation. Vapor Protection Services is offering a Radon Testing $99 Coupon, that can also act as a rebate on a new radon system, in order to reach homebuyers and sellers who regularly buy radon systems from unethical contractors and may not understand that radon really is the leading...

2014-06-19 12:30:33

Surveyed Payers Are Most Receptive to Therapies Offering a Median Overall Survival Benefit over Available Therapies, According to a New Report from Decision Resources Group BURLINGTON, Mass., June 19, 2014 /PRNewswire/ -- Decision Resources Group (DRG) finds that, according to surveyed U.S. and European oncologists, improvement in efficacy endpoints are the most influential factors in prescribing decisions for previously treated EGFR wild-type/untested non-small-cell lung cancer (NSCLC). DRG...

2014-06-17 04:21:42

Proof-of-Concept Trial Targets DNA Repair in Bile Duct Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, June 17, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc. announced today that the Company has initiated a randomized Phase 1b/2 Trial of CX-4945 in combination with gemcitabine and cisplatin for the frontline treatment of patients with bile duct cancers (cholangiocarcinoma). This Proof-of-Concept trial will study the use of CX-4945, a small molecule CK2 inhibitor, to suppress...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.